Appropriateness and surveillance of medication in a cohort of diabetic patients on polypharmacy

International Journal of Clinical Pharmacology and Therapeutics

Volumn 47, Issue 2, 2009, Pages 104-110

  Harder, S ^a   Saal, K ^a   Blauth, E ^a   Beyer, M ^a   Gerlach, F M ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Diabetes; Pharmacoepidemiology; Polypharmacy

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INSULIN; MAGNESIUM; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; PROTON PUMP INHIBITOR; VITAMIN; DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; FEMALE; GENERAL PRACTITIONER; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POLYPHARMACY; PRESCRIPTION; SEX DIFFERENCE; ATTITUDE TO HEALTH; CLINICAL PRACTICE; DOCUMENTATION; FACTUAL DATABASE; INFORMATION PROCESSING; MIDDLE AGED; PATIENT EDUCATION; RISK; RISK FACTOR; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DATA COLLECTION; DATABASES, FACTUAL; DIABETES MELLITUS; DOCUMENTATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; POLYPHARMACY; RISK; RISK FACTORS;

EID: 62749194583     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP47104     Document Type: Article

References (32)

1. Baglin A, Boulard JC, Hanslik T, Prinseau J. Metabolic adverse reactions to diuretics. Clinical relevance to elderly patients. Drug Saf. 1995; 12: 161-167.
2. Baker DW, Wolf MS, Feinglass J, Thompson JA, Gazmararian JA, Huang J. Health literacy and mortality among elderly persons. Arch Intern Med. 2007; 167: 1503-1509.
3. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001; 51: 615-622.
4. Bergk V, Gasse C, Rothenbacher D, Loew M, Brenner H, Haefeli WE. Drug interactions in primary care: impact of a new algorithm on risk determination. Clin Pharmacol Ther. 2004; 76: 85-96.
5. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005; 294: 716-724.
6. Coste J, Venot A. An epidemiologic approach to drug prescribing quality assessment. Med Care. 1999; 37: 1294-1307.
7. Cullen G, Kelly E, Murray FE. Patients' knowledge of adverse reactions to current medications. Br J Clin Pharmacol. 2006; 62: 232-236.
8. Feely J, McGettigan P, Kelly A. Growth in use of statins after trials is not targeted to most appropriate patients. Clin Pharmacol Ther. 2000; 67: 438-441.
9. Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, Reissigová J, Bernabei R, AdHOC Project Research Group. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005; 293: 1348-1358.
10. Gérardin-Marais M, Victorri-Vigneau C, Allain-Veyrac G, Chaslerie A, Nicolas M, Sarraf N, Pivette J, Jolliet P. Diuretic drug therapy monitoring in the elderly: a cohort study. Eur J Clin Pharmacol. 2008; 64: 433-437.
11. Harder S, Fischer P, Krause-Schäfer M, Ostermann K, Helms G, Prinz H, Hahmann M, Baas H. Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany. Eur J Clin Pharmacol. 2005; 60: 797-805.
12. Harder S, Mohr O, Klepzig H. Lipid-lowering treatment coronary artery disease: a pharmacoepidemiological survey in an outpatient clinic in Germany. Int J Clin Pharmacol Ther. 2001; 39: 534-539.
13. Harder S, Thurmann PA, Thierolf Ch, Klepzig H. Prescription of cardiovascular drugs in ambulatory care: a survey of ambulatory patients in a German University Hospital. Int J Clin Pharmacol Ther. 1998; 36: 195-201.
14. Jonville-Béra AP, Paroux L, Autret-Leca E. Assessing general practitioners' prescribing behavior in elderly patients with concealed renal failure. Br J Clin Pharmacol. 2008; Mar 13, Epub ahead of print.
15. Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients inGermany. FamPract. 2007; 24: 14-19.
16. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003; 289: 1652-1658.
17. Kerek-Bodden H, Koch H, Brenner G, Flatten G. Diagnostic spectrum and treatment requirements of general practice clients. Results of the ADT panel of the Central Institute of National Health Insurance Management (German). Z Ärztl Fortbild Qualitatssich. 2000; 94: 21-30.
18. Komajda M. The EuroHeart Failure Survey programme- a survey on the quality of care among patients with heart failure in Europe. Part 2: Treatment. Eur Heart J. 2003; 24: 464-474.
19. Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA, OLDY (OLd people Drugs and dysregulations) Study Group. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2008; 65: 130-133.
20. Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007a; 63: 725-731.
21. Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol. 2007b; 63: 177-186.
22. Lewis SJ. Statin therapy in the elderly: observational and randomized controlled trials support event reduction. Am J Geriatr Cardiol. 2004; 13 (Suppl. 1): 10-16.
23. Long CL et al. Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother. 2004; 38: 853.
24. Meredith S, Feldman P, Frey D, Hall K, Arnold K, Brown NJ, Ray WA. Possible medication errors in home healthcare patients. J Am Geriatr Soc. 2001; 49: 719-724.
25. Munar MY, Singh H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Physician. 2007; 75: 1487.
26. Okuno J, Yanagi H, Tomura S, Oka M, Hara S, Hirano C, Tsuchiya S. Compliance and medication knowledge among elderly Japanese home-care recipients. Eur J Clin Pharmacol. 1999; 55: 145-149.
27. Palmer BF, Gates JR, Lader M. Causes and management of hyponatremia. Ann Pharmacother. 2003; 37: 1694-1702.
28. Papanikolaou PN, Ioannidis JPA. Awareness of the side effects of possessed medications in a community setting. Eur J Clin Pharmacol. 2003; 58: 821-827.
29. Roe CM, Motheral BR, Teitelbaum F, Rich MW. Compliance with and dosing of angiotensin-converting enzyme inhibitors before and after hospitalization. Am J Health Syst Pharm. 2000; 57: 139-145.
30. Rottlaender D, Scherner M, Schneider T, Erdmann E. Polypharmacy, compliance and nonprescription medication in patients with cardiovascular disease in Germany. Dtsch Med Wochenschr. 2007; 132: 139-144.
31. Siu AL, Kravitz RL, Keeler E, Hemmerling K, Kington R, Davis JW, Mitchell A, Burton TM, Morgenstern H, Beers MH, Reuben DB. Postdischarge geriatric assessment of hospitalized frail elderly patients. Arch Intern Med. 1996; 156: 76-81.
32. Stuck AE. Inappropriate medication use in community residing older persons. Arch Intern Med. 1994; 154: 2195-2200.